Mobilizing Domestic Support for International Vaccine Solidarity - Recommendations for Health Crisis Communication

Overview

Journal NPJ Vaccines

Date 2023 Feb 28

PMID 36854782

Authors

Dirk Leuffen

Pascal Mohamed Mounchid

Max Heermann

Sebastian Koos

Affiliations

Soon will be listed here.

References

McAdams D, McDade K, Ogbuoji O, Johnson M, Dixit S, Yamey G . Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective. BMJ Glob Health. 2020; 5(11). PMC: 7705419. DOI: 10.1136/bmjgh-2020-003627. View

Wagner C, Saad-Roy C, Morris S, Baker R, Mina M, Farrar J . Vaccine nationalism and the dynamics and control of SARS-CoV-2. Science. 2021; 373(6562):eabj7364. PMC: 9835930. DOI: 10.1126/science.abj7364. View

Lampert A, Sulitzeanu-Kenan R, Vanhuysse P, Tepe M . A game theoretic approach identifies conditions that foster vaccine-rich to vaccine-poor country donation of surplus vaccines. Commun Med (Lond). 2022; 2:107. PMC: 9395896. DOI: 10.1038/s43856-022-00173-w. View

Klumpp M, Monfared I, Vollmer S . Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States. Vaccine. 2022; 40(16):2457-2461. PMC: 8890975. DOI: 10.1016/j.vaccine.2022.02.084. View

Kobayashi Y, Heinrich T, Bryant K . Public support for development aid during the COVID-19 pandemic. World Dev. 2020; 138:105248. PMC: 7577681. DOI: 10.1016/j.worlddev.2020.105248. View

Steinert J, Sternberg H, Veltri G, Buthe T . How should COVID-19 vaccines be distributed between the Global North and South: a discrete choice experiment in six European countries. Elife. 2022; 11. PMC: 9592081. DOI: 10.7554/eLife.79819. View

Telenti A, Arvin A, Corey L, Corti D, Diamond M, Garcia-Sastre A . After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021; 596(7873):495-504. DOI: 10.1038/s41586-021-03792-w. View

Clarke P, Roope L, Loewen P, Bonnefon J, Melegaro A, Friedman J . Public opinion on global rollout of COVID-19 vaccines. Nat Med. 2021; 27(6):935-936. DOI: 10.1038/s41591-021-01322-9. View

Binagwaho A, Mathewos K, Davis S . Time for the ethical management of COVID-19 vaccines. Lancet Glob Health. 2021; 9(8):e1169-e1171. PMC: 8096324. DOI: 10.1016/S2214-109X(21)00180-7. View

10.

Vanhuysse P, Jankowski M, Tepe M . Vaccine alliance building blocks: a conjoint experiment on popular support for international COVID-19 cooperation formats. Policy Sci. 2021; 54(3):493-506. PMC: 8355869. DOI: 10.1007/s11077-021-09435-1. View

11.

Wouters O, Shadlen K, Salcher-Konrad M, Pollard A, Larson H, Teerawattananon Y . Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021; 397(10278):1023-1034. PMC: 7906643. DOI: 10.1016/S0140-6736(21)00306-8. View

12.

Bechtel M, Scheve K . Mass support for global climate agreements depends on institutional design. Proc Natl Acad Sci U S A. 2013; 110(34):13763-8. PMC: 3752231. DOI: 10.1073/pnas.1306374110. View

13.

Lazarus J, Romero D, Kopka C, Karim S, Abu-Raddad L, Almeida G . A multinational Delphi consensus to end the COVID-19 public health threat. Nature. 2022; 611(7935):332-345. PMC: 9646517. DOI: 10.1038/s41586-022-05398-2. View